define digital currency, People searches

Sumitomo Rubber said that the price of domestic commercial tires and related products increased on April 1, 2025. Sumitomo Rubber raised the price of Japanese tires by 6-8% on average.In the communication service sector, the daily limit of Bee Assistant was higher, and the communication service sector was higher. The daily limit of Xiangjiang and Bee Assistant in the city was higher. Three-dimensional communication and Beiwei Technology were previously closed, and Runze Technology rose by more than 10%. Century Hengtong, Halo New Network, Chaoxun Communication, Guangmai Technology and Runjian shares followed suit.EDI SUSIANTO, Executive Director of the Bank of Indonesia: The decline of the Indonesian rupiah was affected by global sentiment and the rise of the US dollar.

Vista Jiajie: The development of cloud computing and digitalization in Asia-Pacific IT distribution is accelerating. According to the research report of CLSA, Vista Jiajie, as the eighth largest IT distributor in the world and the second largest IT distributor in China, has benefited from the rapid growth of cloud computing and the digitalization development in Southeast Asia, and has a good market position. The company occupies a dominant position in the ICT industry in the Asia-Pacific region, especially in Southeast Asia and China, with obvious demographic advantages and huge growth potential. Vista Jiajie is Starlink's preferred partner in ASEAN. The global cloud computing market is expected to grow at a compound annual growth rate of 18.6% from 2023 to 2027. Vista Jiajie has an optimistic prospect in the fields of cloud computing and artificial intelligence.The Philippines' current account deficit in the third quarter was $5.7 billion.Tin Venture Capital and other companies have invested 300 million yuan in establishing low-altitude economic equity investment partnership. According to Tianyancha App, recently, Wuxi Liangxi Science and Technology City Xichuang Low-altitude economic equity investment partnership (limited partnership) was established. The executive partner is Wuxi Guolian Industrial Investment Private Equity Fund Management Co., Ltd., with a capital contribution of 300 million yuan. Its business scope includes investment activities and venture capital with its own funds, and it is invested by Wuxi Innovation Investment Group Co., Ltd., Wuxi Xiangyun Investment Co., Ltd. and Wuxi Liangxi Science and Technology City.

Turkish regulators blocked access to dozens of cryptocurrency exchanges, and the Turkish Capital Markets Board listed websites that allegedly provided unauthorized cryptoasset services to Turkish customers.Market News: The motion of impeaching South Korean President Yin Xiyue was reported to the South Korean National Assembly.CMB International: Upgraded the target price of WuXi Bio to HK$ 22.88, optimistic about the company's valuation and performance repair. CMB International published a report, predicting that the US Biosafety Act will fail with high probability, which will help WuXi Bio to achieve continuous performance growth in a relatively stable business environment. With the recovery of global biomedical financing, we are optimistic about the company's valuation and performance repair. According to the report, the NDAA in FY 2025 does not include the Biosafety Act, and the legislation of the Biosafety Act failed with high probability. On December 7, the US Senate and the House Armed Services Committee announced the National Defense Authorization Act (NDAA) for fiscal year 2025, which was finally negotiated by the committees of the two houses. The Biosafety Act was not included in the amendment of NDAA in FY 2025, which means that the Biosafety Act failed to pass the legislative path of joining NDAA. The Biosafety Act can still promote separate legislation, but considering that the window of the current US Congress session is less than two weeks, the Bank believes that the success rate of separate legislation is extremely low. CMB International maintained the "Buy" rating of Yaoming Bio, and its target price rose from HK$ 13.58 to HK$ 22.88. It is estimated that the company's revenue will increase by 7.1%/12.4%/ 13.9% from 2024 to 2026, and its adjusted net profit will increase by 0.8%/11.1%/13.4% respectively.